{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T23:39:17Z","timestamp":1788910757188,"version":"build-2803163510"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004826","name":"Natural Science Foundation of Beijing Municipality","doi-asserted-by":"publisher","award":["7202138"],"award-info":[{"award-number":["7202138"]}],"id":[{"id":"10.13039\/501100004826","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.intimp.2022.108891","type":"journal-article","created":{"date-parts":[[2022,6,9]],"date-time":"2022-06-09T17:42:40Z","timestamp":1654796560000},"page":"108891","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Pathophysiology and system biology of rat c-BSA induced immune complex glomerulonephritis and pathway comparison with human gene sequencing data"],"prefix":"10.1016","volume":"109","author":[{"given":"Haijie","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Binghan","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaodi","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoyu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaojun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weida","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoguang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.intimp.2022.108891_b0005","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nrneph.2017.155","article-title":"Dyslipidaemia in nephrotic syndrome: mechanisms and treatment","volume":"14","author":"Agrawal","year":"2018","journal-title":"Nat. Rev. Nephrol."},{"issue":"8","key":"10.1016\/j.intimp.2022.108891_b0010","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1136\/annrheumdis-2017-212935","article-title":"Metabolic pathways and immunometabolism in rare kidney diseases","volume":"77","author":"Grayson","year":"2018","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.intimp.2022.108891_b0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2017\/7689254","article-title":"Recent Treatment Advances and New Trials in Adult Nephrotic Syndrome","volume":"2017","author":"K\u00f6nigshausen","year":"2017","journal-title":"Biomed. Res. Int."},{"issue":"6","key":"10.1016\/j.intimp.2022.108891_b0020","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1111\/j.1440-1827.1978.tb01276.x","article-title":"Bovine serum albumin (BSA) nephritis in rats. I. Experimental model","volume":"28","author":"Yamamoto","year":"1978","journal-title":"Acta pathologica japonica"},{"issue":"6","key":"10.1016\/j.intimp.2022.108891_b0025","first-page":"660","article-title":"Bovine serum albumin (BSA) nephritis in rats II. Histological findings and complement activation by immune complex in SHR rats","volume":"64","author":"Yamamoto","year":"1983","journal-title":"Br. J. Exp. Pathol."},{"issue":"2","key":"10.1016\/j.intimp.2022.108891_b0030","first-page":"293","article-title":"Bovine serum albumin (BSA) nephritis in rats. III. Antigen distribution in various organs","volume":"59","author":"Miyazaki","year":"1985","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.intimp.2022.108891_b0035","article-title":"Deficiency of Carbonic Anhydrase II Results in a Urinary Concentrating Defect","volume":"8","author":"Krishnan","year":"2017","journal-title":"Front. Physiol."},{"issue":"10","key":"10.1016\/j.intimp.2022.108891_b0040","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1093\/ndt\/gft071","article-title":"Animal models of chronic kidney disease: useful but not perfect","volume":"28","author":"Becker","year":"2013","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.intimp.2022.108891_b0045","article-title":"Skimmin, a Coumarin from Hydrangea paniculata, Slows down the Progression of Membranous Glomerulonephritis by Anti-Inflammatory Effects and Inhibiting Immune Complex Deposition","volume":"2013","author":"Zhang","year":"2013","journal-title":"Evid Compl. Alternat. Med."},{"key":"10.1016\/j.intimp.2022.108891_b0050","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2017.00872","article-title":"Total Coumarins from Hydrangea paniculata Show Renal Protective Effects in Lipopolysaccharide-Induced Acute Kidney Injury via Anti-inflammatory and Antioxidant Activities","volume":"8","author":"Zhang","year":"2017","journal-title":"Front. Pharmacol."},{"issue":"10","key":"10.1016\/j.intimp.2022.108891_b0055","first-page":"975","article-title":"Ultrastructural changes in the remnant kidney (after 5\/6 nephrectomy) glomerulus after losartan and atenolol treatment","volume":"39","author":"Aunapuu","year":"2003","journal-title":"Medicina (Kaunas)."},{"key":"10.1016\/j.intimp.2022.108891_b0060","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.phymed.2018.12.045","article-title":"Coumarin glycosides from Hydrangea paniculata slow down the progression of diabetic nephropathy by targeting Nrf2 anti-oxidation and smad2\/3-mediated profibrosis","volume":"57","author":"Sen","year":"2019","journal-title":"Phytomedicine"},{"issue":"1","key":"10.1016\/j.intimp.2022.108891_b0065","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1186\/s12920-019-0570-z","article-title":"Transcriptome sequencing of lncRNA, miRNA, mRNA and interaction network constructing in coronary heart disease","volume":"12","author":"Liao","year":"2019","journal-title":"BMC Med. Genomics"},{"issue":"11","key":"10.1016\/j.intimp.2022.108891_b0070","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1101\/gr.1239303","article-title":"Cytoscape: a software environment for integrated models of biomolecular interaction networks","volume":"13","author":"Shannon","year":"2003","journal-title":"Genome Res."},{"issue":"3","key":"10.1016\/j.intimp.2022.108891_b0075","first-page":"132","article-title":"An update on the use of mycophenolate mofetil in lupus nephritis and other primary glomerular diseases","volume":"5","author":"Appel","year":"2009","journal-title":"Nature Clin. Practice Nephrol."},{"issue":"2","key":"10.1016\/j.intimp.2022.108891_b0080","first-page":"2195","article-title":"KIF9AS1, LINC01272 and DIO3OS lncRNAs as novel biomarkers for inflammatory bowel disease","volume":"17","author":"Wang","year":"2018","journal-title":"Mol. Med. Rep."},{"issue":"1","key":"10.1016\/j.intimp.2022.108891_b0085","doi-asserted-by":"crossref","DOI":"10.1186\/s13073-015-0162-2","article-title":"Transcriptomic landscape of lncRNAs in inflammatory bowel disease","volume":"7","author":"Mirza","year":"2015","journal-title":"Genome Med."},{"issue":"5","key":"10.1016\/j.intimp.2022.108891_b0090","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1084\/jem.113.5.899","article-title":"Experimental glomerulonephritis. The pathogenesis of a laboratory model resembling the spectrum of human glomerulonephritis","volume":"113","author":"Dixon","year":"1961","journal-title":"J. Exp. Med."},{"issue":"1","key":"10.1016\/j.intimp.2022.108891_b0095","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.jep.2010.06.020","article-title":"Effects of sodium houttuyfonate on expression of NF-kappaB and MCP-1 in membranous glomerulonephritis","volume":"131","author":"Pan","year":"2010","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.intimp.2022.108891_b0100","doi-asserted-by":"crossref","first-page":"3735","DOI":"10.2147\/DDDT.S213088","article-title":"Renoprotective Effects Of Isoliquiritin Against Cationic Bovine Serum Albumin-Induced Membranous Glomerulonephritis In Experimental Rat Model Through Its Anti-Oxidative And Anti-Inflammatory Properties","volume":"13","author":"Liu","year":"2019","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.intimp.2022.108891_b0105","doi-asserted-by":"crossref","first-page":"107027","DOI":"10.1016\/j.intimp.2020.107027","article-title":"Upregulation of FoxO3a expression through PI3K\/Akt pathway attenuates the progression of lupus nephritis in MRL\/lpr mice","volume":"89","author":"Zhao","year":"2020","journal-title":"Int. Immunopharmacol."},{"issue":"2","key":"10.1016\/j.intimp.2022.108891_b0110","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.apsb.2020.10.001","article-title":"Long non-coding RNAs: from disease code to drug role","volume":"11","author":"Chen","year":"2021","journal-title":"Acta Pharmaceutica Sinica B"},{"issue":"6","key":"10.1016\/j.intimp.2022.108891_b0115","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1016\/j.kint.2017.12.028","article-title":"Actin dynamics at focal adhesions: a common endpoint and putative therapeutic target for proteinuric kidney diseases","volume":"93","author":"Sever","year":"2018","journal-title":"Kidney Int."},{"issue":"23","key":"10.1016\/j.intimp.2022.108891_b0120","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1617004114","article-title":"The FERM protein EPB41L5 regulates actomyosin contractility and focal adhesion formation to maintain the kidney filtration barrier","volume":"114","author":"Schell","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.intimp.2022.108891_b0125","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1681\/ASN.2005070714","article-title":"Toll-like receptor-7 modulates immune complex glomerulonephritis","volume":"17","author":"Pawar","year":"2006","journal-title":"J. Am. Soc. Nephrol."},{"issue":"12","key":"10.1016\/j.intimp.2022.108891_b0130","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1038\/nrrheum.2016.186","article-title":"New insights into the immunopathogenesis of systemic lupus erythematosus","volume":"12","author":"Tsokos","year":"2016","journal-title":"Nat. Rev. Rheumatol."},{"issue":"1","key":"10.1016\/j.intimp.2022.108891_b0135","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jaut.2007.04.004","article-title":"Coactivation of Toll-like receptor-3 and -7 in immune complex glomerulonephritis","volume":"29","author":"Patole","year":"2007","journal-title":"J. Autoimmun."},{"issue":"12","key":"10.1016\/j.intimp.2022.108891_b0140","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1136\/annrheumdis-2018-213028","article-title":"Increased autophagy is cytoprotective against podocyte injury induced by antibody and interferon-alpha in lupus nephritis","volume":"77","author":"Qi","year":"2018","journal-title":"Ann. Rheum. Dis."},{"issue":"5","key":"10.1016\/j.intimp.2022.108891_b0145","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1080\/15548627.2019.1580512","article-title":"Podocytes and autophagy: a potential therapeutic target in lupus nephritis","volume":"15","author":"Zhou","year":"2019","journal-title":"Autophagy"},{"issue":"4","key":"10.1016\/j.intimp.2022.108891_b0150","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.jaut.2012.04.006","article-title":"Immune complex-mediated co-ligation of the BCR with FcgammaRIIB results in homeostatic apoptosis of B cells involving Fas signalling that is defective in the MRL\/Lpr model of systemic lupus erythematosus","volume":"39","author":"Paunovic","year":"2012","journal-title":"J. Autoimmun."},{"issue":"2","key":"10.1016\/j.intimp.2022.108891_b0155","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/j.1365-2249.2011.04332.x","article-title":"The absence of immunoglobulin D B cell receptor-mediated signals promotes the production of autoantibodies and exacerbates glomerulonephritis in murine lupus","volume":"164","author":"Guo","year":"2011","journal-title":"Clin. Exp. Immunol."},{"issue":"2","key":"10.1016\/j.intimp.2022.108891_b0160","first-page":"236","article-title":"A comprehensive overview of lncRNA annotation resources","volume":"18","author":"Xu","year":"2017","journal-title":"Brief Bioinform."},{"key":"10.1016\/j.intimp.2022.108891_b0165","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.60583","article-title":"Beyond the RNA-dependent function of LncRNA genes","volume":"9","author":"Ali","year":"2020","journal-title":"Elife"},{"issue":"18","key":"10.1016\/j.intimp.2022.108891_b0170","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1101\/gad.17446611","article-title":"Integrative annotation of human large intergenic noncoding RNAs reveals global properties and specific subclasses","volume":"25","author":"Cabili","year":"2011","journal-title":"Genes Dev."},{"key":"10.1016\/j.intimp.2022.108891_b0175","doi-asserted-by":"crossref","first-page":"144279","DOI":"10.1016\/j.gene.2019.144279","article-title":"Effect of the traditional Chinese medicine Qi Teng Xiao Zhuo granules on chronic glomerulonephritis rats studied by using long noncoding RNAs expression profiling","volume":"728","author":"Wei","year":"2020","journal-title":"Gene"},{"key":"10.1016\/j.intimp.2022.108891_b0180","doi-asserted-by":"crossref","first-page":"975","DOI":"10.3389\/fimmu.2019.00975","article-title":"Identification of Renal Long Non-coding RNA RP11-2B6.2 as a Positive Regulator of Type I Interferon Signaling Pathway in Lupus Nephritis","volume":"10","author":"Liao","year":"2019","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.intimp.2022.108891_b0185","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.bbrc.2020.08.073","article-title":"LncRNA CTBP1-AS2 alleviates high glucose-induced oxidative stress, ECM accumulation, and inflammation in diabetic nephropathy via miR-155-5p\/FOXO1 axis","volume":"532","author":"Wang","year":"2020","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"3","key":"10.1016\/j.intimp.2022.108891_b0190","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1007\/s00441-020-03248-z","article-title":"LncRNA NEAT1 accelerates renal mesangial cell injury via modulating the miR-146b\/TRAF6\/NF-kappaB axis in lupus nephritis","volume":"382","author":"Zhang","year":"2020","journal-title":"Cell Tissue Res."},{"issue":"21","key":"10.1016\/j.intimp.2022.108891_b0195","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1056\/NEJMoa043731","article-title":"Mycophenolate mofetil or intravenous cyclophosphamide for lupus nephritis","volume":"353","author":"Ginzler","year":"2005","journal-title":"New Engl. J. Med."},{"issue":"3","key":"10.1016\/j.intimp.2022.108891_b0200","first-page":"268","article-title":"Membranous nephropathy","volume":"20","author":"Ponticelli","year":"2007","journal-title":"J. Nephrol."},{"issue":"3","key":"10.1016\/j.intimp.2022.108891_b0205","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1007\/s00467-020-04736-8","article-title":"Therapy and outcomes of C3 glomerulopathy and immune-complex membranoproliferative glomerulonephritis","volume":"36","author":"Khandelwal","year":"2021","journal-title":"Pediatr. Nephrol."},{"issue":"5","key":"10.1016\/j.intimp.2022.108891_b0210","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1517\/13543781003765461","article-title":"The accumulated experience with the use of mycophenolate mofetil in primary glomerulonephritis","volume":"19","author":"Koukoulaki","year":"2010","journal-title":"Expert Opin. Invest. Drugs"},{"issue":"suppl_1","key":"10.1016\/j.intimp.2022.108891_b0215","doi-asserted-by":"crossref","first-page":"i100","DOI":"10.1093\/rheumatology\/kew417","article-title":"Research and therapeutics-traditional and emerging therapies in systemic lupus erythematosus","volume":"56","author":"Davis","year":"2017","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.intimp.2022.108891_b0220","doi-asserted-by":"crossref","first-page":"173580","DOI":"10.1016\/j.ejphar.2020.173580","article-title":"Therapeutic potential and molecular mechanisms of mycophenolic acid as an anticancer agent","volume":"887","author":"Benjanuwattra","year":"2020","journal-title":"Eur. J. Pharmacol."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576922003757?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576922003757?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T17:44:20Z","timestamp":1761587060000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576922003757"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":44,"alternative-id":["S1567576922003757"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2022.108891","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pathophysiology and system biology of rat c-BSA induced immune complex glomerulonephritis and pathway comparison with human gene sequencing data","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2022.108891","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108891"}}